Screener
Assembly Biosciences ASMB Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 19,583 | 19,360 |
| Loss from operations | (11,370) | (9,941) |
| Other income | ||
| Interest and other income, net | 2,291 | 1,123 |
| Total other income | 2,291 | 1,123 |
| Net loss | $(9,079) | $(8,818) |
| Other comprehensive loss | ||
| Unrealized loss on marketable securities | 327 | 42 |
Item 1. Financial Statements
FAQ
- What is Assembly Biosciences's interest income?
- Assembly Biosciences (ASMB) reported interest income of $2.29M in Q1 2026.
- How has Assembly Biosciences's interest income changed year-over-year?
- Assembly Biosciences's interest income increased by 104.0% year-over-year, from $1.12M to $2.29M.
- What is the long-term trend for Assembly Biosciences's interest income?
- Over 4 years (2021 to 2025), Assembly Biosciences's interest income has grown at a 111.1% compound annual growth rate (CAGR), from $302K to $6M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Assembly Biosciences's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude